Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For 000507.SZ
Valuation Weak
14%
Profitability n.A.
Fin. Growth Positive
67%
Leverage & Liquidity Weak
17%
Per Share Metrics Weak
33%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio 12.70 1.17 1.04
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 27.29 26.67 20.96
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 0.11 5.45 5.45
Cash -14.41 1.76 2.05
Capex 31.16 -0.07 -0.10
Free Cash Flow 149.38 0.30 0.12
Revenue -3.72 1.10 1.14
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin 7.98 0.25 0.23
Operating Margin 71.33 0.12 0.07
ROA 18.07 < 0.005 < 0.005
ROE 16.35 < 0.005 < 0.005
ROIC 29.97 < 0.005 < 0.005
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of 000507.SZ is permitted for members.
5 Growth
The "Growth Entry" for the Focus of 000507.SZ is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of 000507.SZ is permitted for members.